Literature DB >> 12215336

Hydrosalpinx fluid diminishes endometrial cell HOXA10 expression.

Gaurang S Daftary1, Hugh S Taylor.   

Abstract

OBJECTIVE: To determine the effect of hydrosalpinx fluid on the expression of HOXA10, an essential regulator of endometrial receptivity.
DESIGN: In vitro study.
SETTING: Academic medical center. PATIENT(S): Patients with unilateral or bilateral hydrosalpinx. INTERVENTION(S): Hydrosalpinx fluid was aspirated from 10 patients at laparoscopy. The fluid was serially diluted in minimum essential medium. Ishikawa cells (an endometrial adenocarcinoma cell line, representative of endometrial epithelium) were incubated with this fluid at concentrations of 10% and 50% for 48 hours. Cells were also incubated in undiluted minimum essential medium (MEM) and in 10% serum as controls. After incubation, the cells were lysed in Trizol, and total RNA was extracted and analyzed by Northern blot using a 32P-labeled HOXA10 riboprobe. A 32P-labeled G3PDH probe was used as a control for loading. MAIN OUTCOME MEASURE(S): HOXA10 mRNA expression. RESULT(S): HOXA10 mRNA expression in endometrial cells decreased with increasing concentrations of hydrosalpinx fluid. Densitometric analysis of the northern blot revealed that HOXA10 mRNA expression was different from control at both concentrations (P<.007). CONCLUSION(S): HOXA10 is necessary for implantation in the murine model. HOXA10 expression is diminished by hydrosalpinx fluid. This effect on HOXA10 is a potential molecular mechanism by which implantation rates are diminished in women with hydrosalpinges.

Entities:  

Mesh:

Year:  2002        PMID: 12215336     DOI: 10.1016/s0015-0282(02)03306-x

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  21 in total

Review 1.  Transcriptional regulation of implantation by HOX genes.

Authors:  Hugh S Taylor
Journal:  Rev Endocr Metab Disord       Date:  2002-05       Impact factor: 6.514

Review 2.  Implantation failure: molecular mechanisms and clinical treatment.

Authors:  Hakan Cakmak; Hugh S Taylor
Journal:  Hum Reprod Update       Date:  2010-08-21       Impact factor: 15.610

3.  A novel role for the AAA ATPase spastin as a HOXA10 transcriptional corepressor in Ishikawa endometrial cells.

Authors:  Gaurang S Daftary; Amy M Tetrault; Elisa M Jorgensen; Jennifer Sarno; Hugh S Taylor
Journal:  Mol Endocrinol       Date:  2011-07-14

4.  Regulatory effect of estrogen, progestin and HB-EGF on the expression of HOXA10 gene in Ishikawa cells.

Authors:  Xuemei Liu; Guijin Zhu; Gang Zhong
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2007-08

5.  HOXA10 regulates endometrial GABAA {pi} receptor expression and membrane translocation.

Authors:  Homayoun Sadeghi; Hugh S Taylor
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-01-26       Impact factor: 4.310

6.  GnRH antagonists may affect endometrial receptivity.

Authors:  Beth W Rackow; Harvey J Kliman; Hugh S Taylor
Journal:  Fertil Steril       Date:  2008-04-14       Impact factor: 7.329

Review 7.  Epigenetic control of embryo-uterine crosstalk at peri-implantation.

Authors:  Shuangbo Kong; Chan Zhou; Haili Bao; Zhangli Ni; Mengying Liu; Bo He; Lin Huang; Yang Sun; Haibin Wang; Jinhua Lu
Journal:  Cell Mol Life Sci       Date:  2019-07-27       Impact factor: 9.261

8.  Endometrial polyps affect uterine receptivity.

Authors:  Beth W Rackow; Elisa Jorgensen; Hugh S Taylor
Journal:  Fertil Steril       Date:  2011-01-26       Impact factor: 7.329

9.  Aberrant HOXA10 Methylation in Patients With Common Gynecologic Disorders: Implications for Reproductive Outcomes.

Authors:  Jennifer L Kulp; Ramanaiah Mamillapalli; Hugh S Taylor
Journal:  Reprod Sci       Date:  2016-02-10       Impact factor: 3.060

10.  Thrombin and interleukin-1beta decrease HOX gene expression in human first trimester decidual cells: implications for pregnancy loss.

Authors:  Jennifer Sarno; Frederick Schatz; S Joseph Huang; Charles Lockwood; Hugh S Taylor
Journal:  Mol Hum Reprod       Date:  2009-04-22       Impact factor: 4.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.